Mumbai, India: Actofit, a well-known, leading health management company with connected devices, has teamed up with Infigo in Ratnagiri to provide a Diabetes Remission Program for Retinopathy patients among which 90% are Diabetic patients. Diabetic retinopathy is a serious complication of diabetes that affects the eyes.
The Program was designed to help patients with Diabetes in improving their Metabolic Health, and HbA1c level and reduce the level of dependence on medication. The program includes a combination of lifestyle changes and condition management, which has been shown to be effective in reversing Diabetes.
CGM (Continuous Glucose Monitoring) can be a useful device for managing diabetes and preventing complications such as diabetic retinopathy. By providing real-time glucose data, CGM allows for more accurate and precise insulin dosing, which can help prevent both high and low blood sugar levels.
Consistently high blood sugar levels can lead to diabetic retinopathy, which is characterized by damage to the blood vessels in the retina. Over time, this damage can cause vision loss or blindness. The program combines dietary advice, physical activity, medical supervision, and education from the most experienced doctors of Actofit on how to manage your diabetes better into one comprehensive system. The program integrated a holistic approach to diabetes, offering walk-in clinic service to make the experience convenient for the patients.
Actofit has announced its plan to launch walk-in and cloud clinics across 12 centers of Infigo located in Maharashtra. The joint initiative by Actofit and Infigo aims to promote the early detection of diabetes and offer tailored lifestyle solutions to prevent further complications associated with the disease.
Dr. Ketan Pakhale, India’s leading Bariatric and Metabolic Physician, Chief Scientific Officer of Actofit, and an expert in Diabetes and Obesity management expressed, “Actofit’s belief that combined expertise in diabetes and retinopathy management will provide a comprehensive solution for patients, enabling them to lead healthier and happier lives.”
Dr. Shridhar Thakur, Founder, and CEO of Infigo say “We are delighted to partner with Actofit to provide medical facilities to individuals who may not have easy access to healthcare services. We believe that our collaboration with Actofit will make a significant difference in the lives of diabetic patients in Maharashtra.”
Infigo has a wide network of centers across Maharashtra, while Actofit has positively impacted the lives of over one million users and established connections with numerous corporates and gyms in India. Being a leader in the fitness wearable sector, Actofit is excited to collaborate with Infigo to provide medical facilities to individuals residing in rural and remote areas who may not have easy access to healthcare services.
“Diabetes is a significant public health challenge in India, and we are excited to partner with Infigo to provide solutions to this issue,” said Dr. Ateeb Shaikh, Chief Product Officer of Actofit.
Patients enrolled in the program are given a complete dietary program with regularly scheduled follow-ups with one of the most experienced Doctors, Dieticians, and Health coaches of Actofit to ensure success in their health goals.
With the Diabetes Reversal Program in Ratnagiri, Actofit, and Infigo are looking to leverage their combined resources and knowledge to create a holistic approach to better diabetes management.
About Actofit:
Actofit is a leading wearable company with connected devices and inbuilt wellness content. The company’s mission is to make fitness accessible to everyone through innovative technology and personalized content.
For more information about Actofit and its products, please visit www.actofit.com.
About Infigo:
Infigo is a top ophthalmologist in Maharashtra backed by cutting edge technology and bio-science innovations in the hands of super qualified doctors.Their mission is to create a robust, comprehensive eye care infrastructure that provides world-class, timely treatment using cutting edge technology.
For more information, visit www.infigoey.com
